JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AMRN
5601
Amarin Corp
AMRN
$269M
| $77.5K | ﹤0.01% |
4,451
-81
| -2% | -$1.27K |
2016 Q3
29 quarters
|
|
5602
Fulcrum Therapeutics
FULC
$281M
| $77.2K | ﹤0.01% |
11,440
+541
| +5% | +$2.4K |
2019 Q3
17 quarters
|
|
|
FFA
5603
First Trust Enhanced Equity Income Fund
FFA
$444M
| $77K | ﹤0.01% |
4,217
+3,082
| +272% | +$53.2K |
2023 Q2
2 quarters
|
|
5604
PUT
4D Molecular Therapeutics
FDMT
$765M
| $77K | ﹤0.01% |
+3,800
| New | +$50K |
2023 Q4
0 quarters
|
|
|
SRT
5605
DELISTED
Startek Inc.
SRT
| $77K | ﹤0.01% |
17,451
+17,446
| +348,920% | +$73.7K |
2023 Q3
1 quarter
|
|
5606
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.04B
| $76.2K | ﹤0.01% |
3,991
+169
| +4% | +$3.06K |
2022 Q4
4 quarters
|
|
|
NRT
5607
North European Oil Royalty Trust
NRT
$77.2M
| $76K | ﹤0.01% |
13,028
| – | – |
2023 Q2
2 quarters
|
|
5608
Calumet Specialty Products
CLMT
$4.72B
| $75.5K | ﹤0.01% |
4,223
+3,116
| +281% | +$50.5K |
2020 Q4
12 quarters
|
|
5609
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.72B
| $75K | ﹤0.01% |
+2,402
| New | +$71.7K |
2023 Q4
0 quarters
|
|
|
CWBC
5610
DELISTED
Community West BanCshares
CWBC
| $74.8K | ﹤0.01% |
+4,300
| New | +$60K |
2023 Q4
0 quarters
|
|
5611
InfraCap MLP ETF
AMZA
$458M
| $74.7K | ﹤0.01% |
2,114
+30
| +1% | +$1.06K |
2021 Q1
11 quarters
|
|
5612
Oppenheimer Holdings
OPY
$1.28B
| $74.7K | ﹤0.01% |
1,807
+1,446
| +401% | +$55.3K |
2013 Q2
42 quarters
|
|
|
DMK
5613
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $74.4K | ﹤0.01% |
106,209
+71,503
| +206% | +$41.5K |
2021 Q1
11 quarters
|
|
5614
Simplify Hedged Equity ETF
HEQT
$319M
| $74.2K | ﹤0.01% |
2,938
+2,218
| +308% | +$55.2K |
2021 Q4
8 quarters
|
|
5615
CALL
EyePoint Inc
EYPT
$278M
| $74K | ﹤0.01% |
+3,200
| New | +$35.8K |
2023 Q4
0 quarters
|
|
5616
Fidelity Enhanced Large Cap Growth ETF
FELG
$5.8B
| $73.9K | ﹤0.01% |
+2,816
| New | +$72.3K |
2023 Q4
0 quarters
|
|
5617
Cadiz
CDZI
$313M
| $73.6K | ﹤0.01% |
26,297
+8
| +0% | +$24 |
2023 Q2
2 quarters
|
|
5618
InnovAge Holding
INNV
$1.2B
| $73.6K | ﹤0.01% |
12,263
| – | – |
2021 Q1
11 quarters
|
|
5619
DHI Group
DHX
$207M
| $73.5K | ﹤0.01% |
28,372
| – | – |
2019 Q2
18 quarters
|
|
5620
Skillsoft
SKIL
$51M
| $73.4K | ﹤0.01% |
4,178
+4,145
| +12,561% | +$72.5K |
2020 Q1
15 quarters
|
|
|
CCRD
5621
DELISTED
CoreCard
CCRD
| $73.3K | ﹤0.01% |
5,301
+602
| +13% | +$10.1K |
2019 Q2
18 quarters
|
|
|
CTOS.WS
5622
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
| – | – |
0
| – | – |
2023 Q2
2 quarters
|
|
5623
DFA Real Estate Securities Portfolio ETF Class Shares
DFAR
$1.62B
| $73.1K | ﹤0.01% |
3,212
-933
| -23% | -$19.1K |
2022 Q3
5 quarters
|
|
5624
Aclaris Therapeutics
ACRS
$649M
| $73.1K | ﹤0.01% |
69,573
-330,748
| -83% | -$1.01M |
2017 Q4
24 quarters
|
|
5625
WisdomTree Dynamic International SmallCap Equity Fund
DDLS
$418M
| $72.9K | ﹤0.01% |
2,206
-916
| -29% | -$28.3K |
2022 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.